Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Google patents sitagliptin transaminase us application?Wegovy ingredients semaglutide excipients?Januvia vs generic sitagliptin availability 2026?Wegovy cost per month?Synjardy 5 1000 price?
See the DrugPatentWatch profile for Farxiga
Farxiga (dapagliflozin) is used to treat certain conditions related to diabetes and heart/kidney disease. It’s commonly prescribed for: - Type 2 diabetes to improve blood sugar control - Chronic kidney disease (to help slow worsening kidney function) - Heart failure, including in people with reduced ejection fraction, and in some cases heart failure across a broader range of ejection fractions
No. Farxiga is also used for kidney protection and heart failure management in appropriate patients, even when blood sugar control is not the main reason for treatment.
Farxiga belongs to a class of drugs called SGLT2 inhibitors. It lowers blood glucose by helping the kidneys remove glucose in urine, and it also provides benefits to the heart and kidneys through effects that go beyond just sugar lowering.
Common safety questions include dehydration risk, genital yeast infections, and the rare risk of diabetic ketoacidosis (including sometimes with near-normal blood sugar). These are reasons clinicians often review hydration status, other medications, and sick-day rules. If you tell me what you mean by “uses” (for diabetes? for kidney disease? for heart failure? or “what does it do in the body?”), I can tailor the answer to that exact use case.
Other Questions About Farxiga :